CLDN5 and Alzheimer disease: We were particularly interested in the downregulation of CLDN5 mRNA in AD affected CPE, since other investigators [36, 37] previously found variable or low expression of CLDN5 in, respectively, AD affected brain neurons and endothelial cells in the BBB of aging mice.